The Y-receptors belong to the G protein-coupled receptor superfamily a
nd mediate a wide variety of physiological effects, such as regulation
of blood pressure, anxiety, memory retention, hormone release and foo
d intake. Since the first human Y-receptor was cloned in 1992, the sea
rch for additional subtypes has been an area of intense study. Recentl
y four new NPY-receptor subtypes have been isolated, revealing surpris
ingly limited sequence identity with values as low as 30%. Several rep
orts indicate further heterogeneity of this receptor family, for examp
le a peripheral Y-2 receptor. However, since many studies have been ca
rried out with different peptide analogs and radioligands in different
species, there is substantial confusion regarding the pharmacological
profile of the receptors. This may have led to an exaggeration of the
potential number of discrete receptors.